FDA Closes Comment Period for Blueroot Health Nutrient Submission
Summary
The FDA has closed the public comment period for a nutrient submission from Blueroot Health concerning their B6 + B Complex product. The submission was related to energy metabolism support. No further action is required from the public at this time.
What changed
The U.S. Food and Drug Administration (FDA) has closed the public comment period for a nutrient submission from Blueroot Health, identified under docket number FDA-2025-S-0024-1988. The submission pertained to a product named "Vital Nutrients, B6 + B Complex" and its purported support for energy metabolism. The agency has indicated that no further documents are available for viewing or download, and the comment period is now concluded.
For regulated entities, this closure signifies the end of the opportunity to provide input on this specific submission. While no immediate action is required, companies involved in similar nutrient or dietary supplement submissions should be aware that this particular consultation phase has ended. Future FDA actions or guidance related to this submission will be published through official channels.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 1
Blueroot Health - Vital Nutrients, B6 + B Complex - Supports energy metabolism
More Information
- Author(s) HFP
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.